Document is current
Any future updates will be listed below
-
Authors
Mead, Andrew
Toutain, Pierre-Louis
Richez, Pascal
Pelligand, Ludovic
-
Funding
Funding for this research was provided by:
Dopharma
V.M.D./Inovet
Virbac
Biotechnology and Biological Sciences Research Council
- License Information
-
More Information
Article History
Received: 8 December 2022
Accepted: 30 July 2023
First Online: 7 August 2023
Competing interests
: The funding for this study was provided through TransPharm on behalf of Dopharma, V.M.D./Inovet, and Virbac. PR (TransPharm) was involved in the study design, and revision of the submitted article. The funders were not involved in the collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication. AM doctoral stipend was covered by the Bloomsbury studentship (see funding). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
